Skip to Content
  1. Authors
  2. Todd Wenning

Todd Wenning

Todd Wenning, CFA, is an equity analyst for Morningstar.

Latest

Morningstar CEO of the Year finalist John Martin's smart capital-allocation decisions have helped drive a 100-fold increase in this biopharmaceutical's stock since he took over in 1996.